Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

STO/BINV stock hub

STO/BINV has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

STO/BINVis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.5B
Nasdaq Stockholm
Market data

Live price

Current market quote for this ticker.

Current price
STO/BINV
In the news

Latest news · STO/BINV

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-55.5
P25 n/aP50 n/aP75 n/a
ROIC-35.6
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All STO/BINV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
189
Groups with data
11
Currency
SEK
Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Sweden
Country code
SE
Employees
124
Employees Change
9%
Employees Change Percent
7.83
Enterprise value
SEK 1.1B
Exchange
Nasdaq Stockholm
Financial currency
SEK
First seen
2026-05-10
Industry
Biotechnology
Isin
SE0015244520
Last refreshed
2026-05-10
Market cap
SEK 1.5B
Price
SEK 23.1
Price currency
SEK
Rev Per Employee
1,998,697.25x
Sector
Healthcare
Sic
2836
Symbol
sto/BINV
Website
https://www.bioinvent.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-22.07%
EV Earnings
-3.19x
EV/FCF
-4.03x
EV/Sales
4.91x
FCF yield
-17.48%
P/B ratio
3.46x
P/S ratio
6.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

19
MetricValue
EBIT Margin
-160.77%
EBITDA Margin
-155.52%
Gross margin
100%
Gross Profit
SEK 217.9M
Gross Profit Growth
258.3%
Gross Profit Growth Q
-39.15%
Gross Profit Growth3 Y
-12.55%
Gross Profit Growth5 Y
9.74%
Net Income
SEK -335.5M
Net Income Growth Years
1%
Pretax Margin
-153.78%
Profit Margin
-153.98%
Profit Per Employee
SEK -3.1M
ROA
-31.32
Roa5y
-16.69
ROCE
-79.63
ROE
-55.5
Roe5y
-27.43
ROIC
-35.59

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

12
MetricValue
Cagr10y
-8.08%
Cagr15y
-18.51%
Cagr1y
-32.47%
Cagr20y
-11.28%
Cagr3y
-5.64%
Cagr5y
-16.41%
EPS Growth Years
1
Revenue Growth
258.3x
Revenue Growth Q
-39.15x
Revenue Growth Years
1x
Revenue Growth3 Y
-12.55x
Revenue Growth5 Y
9.74x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
SEK 0.31
Assets
SEK 535M
Cash
SEK 456.5M
Current Assets
SEK 505.7M
Current Liabilities
SEK 95.1M
Debt
SEK 6.3M
Debt Equity
SEK 0.01
Debt FCF
SEK -0.02
Equity
SEK 439.1M
Interest Coverage
-871.3
Liabilities
SEK 95.9M
Long Term Assets
SEK 29.3M
Long Term Liabilities
SEK 733,000
Net Cash
SEK 450.2M
Net Cash By Market Cap
SEK 29.62
Net Cash Growth
-38.07%
Net Debt Equity
SEK -1.03
Tangible Book Value
SEK 439.1M
Tangible Book Value Per Share
SEK 6.67
WACC
3.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
5.32
Net Working Capital
SEK -40.4M
Quick ratio
5.2
Working Capital
SEK 410.6M
Working Capital Turnover
SEK 0.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-0.05%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-56.94%
1Y total return
-32.46%
200-day SMA
28.64
3Y total return
-16%
50-day SMA
22.56
50-day SMA vs 200-day SMA
50under200
5Y total return
-59.19%
All Time High
1,350
All Time High Change
-98.29%
All Time High Date
2001-06-18
All Time Low
14
All Time Low Change
65%
All Time Low Date
2023-11-01
ATR
0.92
Beta
-0.05
Beta1y
0.44
Beta2y
0.5
Ch YTD
-21.43
High
23.2
High52
41.6
High52 Date
2025-07-28
High52ch
-44.47%
Low
22.45
Low52
20.85
Low52 Date
2026-03-23
Low52ch
10.79%
Ma50ch
2.38%
Price vs 200-day SMA
-19.35%
RSI
55.33
RSI Monthly
42.04
RSI Weekly
39.2
Sharpe ratio
-0.46x
Sortino ratio
-0.58
Total Return
-0.05%
Tr YTD
-21.43
Tr15y
-95.36%
Tr1m
5.48%
Tr1w
3.59%
Tr3m
-11.15%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
SEK -350.3M
Operating margin
-160.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
31,444,238%
Net Borrowing
-9,030,000
Shares Insiders
0.35%
Shares Institutions
12.45%
Shares Out
65,804,362
Shares Qo Q
0.01%
Shares Yo Y
0.05%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

57
MetricValue
Adjusted FCF
SEK -270.4M
Average Volume
103,873.65x
Bv Per Share
6.67
CAPEX
SEK -5.1M
Ch10y
-57.81
Ch15y
-96.45
Ch1m
5.48
Ch1w
3.59
Ch1y
-32.46
Ch20y
-93
Ch3m
-11.15
Ch3y
-16
Ch5y
-59.19
Ch6m
-27.01
Change
1.32%
Change From Open
2.21
Close
22.8
Days Gap
-0.88
Depreciation Amortization
11,438,000
Dollar Volume
2,877,174.3
Earnings Date
2026-08-27
EBIT
SEK -350.3M
EBITDA
SEK -338.8M
EPS
SEK -5.1
F Score
2
FCF
SEK -265.7M
FCF EV Yield
-24.83x
FCF Per Share
SEK -4.04
Financing CF
-9,030,000
Fiscal Year End
December
Founded
1,996
Income Tax
SEK 431,000
Investing CF
159,635,000
Is Primary Listing
1
Last Earnings Date
2026-03-31
Last Report Date
2026-03-31
Last Split Date
2020-12-14
Last Split Type
Reverse
Ma150
26.8
Ma150ch
-13.82%
Ma20
22.37
Ma20ch
3.27%
Net CF
-118,881,000
Next Earnings Date
2026-08-27
Open
22.6
Position In Range
86.67
Ppne
29,259,000
Price Date
2026-05-08
Ptbv Ratio
3.46
Relative Volume
1.24x
Revenue
217,858,000x
SBC By Revenue
2.17x
Share Based Comp
4,723,000
Tax By Revenue
0.2x
Tr20y
-90.86%
Tr6m
-27.01%
Volume
124,553
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does STO/BINV pay a dividend?

Capital-return profile for this ticker.

Performance

STO/BINV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-32.5%
S&P 500 1Y: n/a
3Y total return
-16.0%
S&P 500 3Y: n/a
5Y total return
-59.2%
S&P 500 5Y: n/a
10Y total return
-56.9%
S&P 500 10Y: n/a
Ownership

Who owns STO/BINV?

Insider, institutional, and short-interest positioning.

Institutional ownership
+12.5%
Share of float held by funds and institutions
Insider ownership
+0.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.1%
Negative means the company is buying back shares.
Technical

STO/BINV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
55.3
Neutral momentum band
Price vs 200-day MA
-19.4%
50/200-day relationship not available
Beta (5Y)
-0.05
Less volatile than the market
Sharpe ratio
-0.46
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About STO/BINV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/BINV stock rating?

sto/BINV is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/BINV analysis?

The full report lives at /stocks/sto/BINV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/BINV?

The latest report frames sto/BINV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/BINV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

sto/BINV stock profile: metrics, valuation and analysis | Agent AI Rynku Akcji